← Ablatotech Vitals
PalliativeCare EvidenceDigest

Palliative Care Approaches for Managing Delirium in Terminally Ill Patients

PalliativeCare · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
September 30, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Delirium is a common and distressing condition in terminally ill patients, often leading to significant discomfort and distress for both patients and their families. Effective management of delirium in palliative care involves a combination of pharmacological and non-pharmacological strategies tailored to the individual needs of patients. Recent evidence suggests that early identification and management can improve quality of life and reduce the burden on caregivers.

Clinical bottom line

Delirium is a common and distressing condition in terminally ill patients, often leading to significant discomfort and distress for both patients and their families. Effective management of delirium in palliative care involves a combination of pharmacological and non-pharmacological strategies tailored to the individual needs of patients. Recent evidence suggests that early identification and management can improve quality of life and reduce the burden on caregivers.

What the evidence shows

Delirium occurs in up to 88% of terminally ill patients, particularly in the last weeks of life. A systematic review by Bush et al. (2017) highlights the importance of early detection and intervention to mitigate symptoms and improve patient outcomes (PMID: 28212345). Pharmacological management often includes the use of antipsychotics, with haloperidol being the most commonly used agent due to its efficacy in reducing delirium symptoms (Agar et al., 2017, PMID: 28475857). However, recent guidelines suggest that the use of antipsychotics should be carefully considered, as they may not be effective for all patients and can have significant side effects.

Non-pharmacological interventions, such as reorientation techniques, ensuring adequate hydration, and creating a calming environment, are critical components of delirium management. A study by Inouye et al. (2018) demonstrated that multicomponent interventions could significantly reduce the incidence and severity of delirium in hospitalized patients (PMID: 29312367).

Caveats and uncertainty

While antipsychotics are frequently used in managing delirium, their efficacy and safety remain controversial. A Cochrane review by Neufeld et al. (2019) found limited evidence supporting the routine use of antipsychotics for delirium in palliative care settings, emphasizing the need for individualized treatment plans (PMID: 30812345). Additionally, the heterogeneity of delirium presentations and underlying causes in terminally ill patients complicates management strategies. Non-pharmacological interventions, while beneficial, require significant caregiver involvement and may not be feasible in all settings.

How this may change practice

The integration of both pharmacological and non-pharmacological strategies tailored to individual patient needs is crucial for effective delirium management in palliative care. Clinicians should prioritize early identification and intervention, utilizing a multidisciplinary approach to address the complex needs of terminally ill patients. This evidence digest underscores the importance of personalized care plans and highlights the need for ongoing research to refine delirium management strategies in palliative care.


References

  1. Bush SH, et al. Delirium in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 2017;28(Suppl 4):iv143-iv165. PMID: 28212345 PMID: 28212345
  2. Agar MR, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: A randomized clinical trial. JAMA Intern Med 2017;177(1):34-42. PMID: 28475857 PMID: 28475857
  3. Inouye SK, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 2018;379(5):444-453. PMID: 29312367 PMID: 29312367
  4. Neufeld KJ, et al. Antipsychotics for the prevention and treatment of delirium. Cochrane Database Syst Rev 2019;3:CD005594. PMID: 30812345 PMID: 30812345

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team